• Members of the previous forum can retrieve their temporary password here, (login and check your PM).

a synchronistic pull in the right direction! my intro

Migrated topic.
D

distrakt

Rising Star
hi all. first time posting to a forum, so deal with it! lol. anyways, i am 37 years old and male. i have been doing drugs since I was 13. started with weed and eventually used MDMA relentlessly in the 90's when you could get good stuff. i also dabbled in research compounds... dxm, amt, 2cb, etc etc. now here is my dilemma. while doing all those illegal drugs i was diagnosed bi polar schizo-effective. they put me on so many different cocktails of meds until they found the right one that worked. now i am on abilify, clozaril, and wellbutrin. so before I try DMT I was wondering if anyone on these meds or similiar ones have tried it and their experiences. i have tried to research these specific ones but i didnt see them in any of the drug lists that should NOT be mixed with DMT. so... with that i think my intro post is done! i am just so glad I found a place like this to read and relate to so many posts already! i just found this site tonight. hopefully you will be hearing a lot from me. i honestly cried a little bit because i finally found somewhere like "home".


-distrakt
 
...we'd advise you that you do not try DMT until you fully recovered from bi polar schizo affective disorder.....unless you are quiet certain that you was misdiagnosed and are a simply a healthy, society non fit outcast
 
" cannabidiol has shown antipsychotic properties in both rodents and rhesus monkeys. After some individual treatment attempts, the first randomized, double-blind controlled clinical trial demonstrated that in acute schizophrenia cannabidiol exerts antipsychotic properties comparable to the antipsychotic drug amisulpride while being accompanied by a superior, placebo-like side effect profile. "

www.ncbi.nlm.nih.gov

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence

There is urgent need for the development of mechanistically different and less side-effect prone antipsychotic compounds. The endocannabinoid system has been suggested to represent a potential new target in this indication. While the chronic use of cannabis ...
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
 
Back
Top Bottom